• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非原发性眼球摘除术治疗单侧视网膜母细胞瘤

The management of unilateral retinoblastoma without primary enucleation.

作者信息

Abramson D H, Marks R F, Ellsworth R M, Tretter P, Kitchin F D

出版信息

Arch Ophthalmol. 1982 Aug;100(8):1249-52. doi: 10.1001/archopht.1982.01030040227002.

DOI:10.1001/archopht.1982.01030040227002
PMID:7103808
Abstract

Sixty-six patients were treated "conservatively" for unilateral retinoblastoma. Forty-eight of 57 (84%) were treated primarily with unilateral radiation, one patient was treated with a cobalt plaque, and eight patients were treated with either cryopexy or xenon arc photocoagulation. With a median follow-up of 73 months, there have been no deaths. Five of 39 eyes that were in groups I to III have been salvaged. Virtually all eyes in groups IV and V (12 of 14) came to enucleation. The age at diagnosis for patients with a positive family history was early (2.5 months), and the patients had a greater number of individual tumors in one eye (2.4), compared with those without a positive family history (27 months, 1.2 tumors per eye). When unilateral retinoblastoma is detected at an early age, the most common sign is strabismus, not leukokoria.

摘要

66例单侧视网膜母细胞瘤患者接受了“保守”治疗。57例中的48例(84%)主要接受单侧放疗,1例接受钴板敷贴治疗,8例接受冷冻疗法或氙弧光凝治疗。中位随访73个月,无死亡病例。I至III组的39只眼中有5只眼视力得以挽救。IV组和V组几乎所有的眼睛(14只中的12只)都接受了眼球摘除术。有家族史阳性的患者诊断时年龄较早(2.5个月),与无家族史阳性的患者相比(27个月,每只眼1.2个肿瘤),这些患者单眼的单个肿瘤数量更多。当单侧视网膜母细胞瘤在早期被检测到时,最常见的体征是斜视,而非白瞳症。

相似文献

1
The management of unilateral retinoblastoma without primary enucleation.非原发性眼球摘除术治疗单侧视网膜母细胞瘤
Arch Ophthalmol. 1982 Aug;100(8):1249-52. doi: 10.1001/archopht.1982.01030040227002.
2
[Radiation management of retinoblastoma].[视网膜母细胞瘤的放射治疗管理]
Nihon Igaku Hoshasen Gakkai Zasshi. 1992 Jun 25;52(6):804-10.
3
The role of photocoagulation in the management of retinoblastoma.光凝在视网膜母细胞瘤治疗中的作用。
Arch Ophthalmol. 1990 Feb;108(2):205-8. doi: 10.1001/archopht.1990.01070040057030.
4
Changing concepts in the management of retinoblastoma.视网膜母细胞瘤治疗理念的转变
Ophthalmic Surg. 1990 Jan;21(1):72-6.
5
Simultaneous bilateral radiation for advanced bilateral retinoblastoma.晚期双侧视网膜母细胞瘤的同步双侧放射治疗。
Arch Ophthalmol. 1981 Oct;99(10):1763-6. doi: 10.1001/archopht.1981.03930020637003.
6
[Conservative treatment of tumors of the retina at the Curie Institute. Long-term results of 129 cases treated with Stallard's disk and electrons].[居里研究所视网膜肿瘤的保守治疗。129例采用斯塔拉德盘和电子治疗的长期结果]
Bull Cancer. 1985;72(2):87-98.
7
[Treatment of retinoblastoma by radioactive cobalt and xenon photocoagulation].
Mod Probl Ophthalmol. 1977;18:118-23.
8
The occurrence of new retinoblastomas after treatment.治疗后新的视网膜母细胞瘤的发生。
Ophthalmology. 1979 May;86(5):837-43. doi: 10.1016/s0161-6420(79)35469-0.
9
[Current treatment of retinoblastoma. 153 children treated between 1995 and 1998].[视网膜母细胞瘤的当前治疗方法。1995年至1998年间接受治疗的153名儿童]
J Fr Ophtalmol. 2000 May;23(5):475-81.
10
Retinoblastoma. A study of 139 cases.视网膜母细胞瘤。139例病例研究。
Br J Ophthalmol. 1971 Jan;55(1):19-27. doi: 10.1136/bjo.55.1.19.

引用本文的文献

1
Ten things you learned in your residency about retinoblastoma that have changed the 2023 Victor T. Curtin Lecture.在住院医师培训期间,你了解到的十件关于视网膜母细胞瘤的事情,改变了 2023 年 Victor T. Curtin 讲座。
Ophthalmic Genet. 2023 Aug;44(4):321-326. doi: 10.1080/13816810.2023.2189948. Epub 2023 Mar 30.
2
At What Age Could Screening for Familial Retinoblastoma Be Discontinued? A Systematic Review.家族性视网膜母细胞瘤筛查在什么年龄可以停止?一项系统评价。
Cancers (Basel). 2021 Apr 17;13(8):1942. doi: 10.3390/cancers13081942.
3
Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy).
双侧视网膜母细胞瘤同步双侧眼动脉化学手术(串联疗法)
PLoS One. 2016 Jun 3;11(6):e0156806. doi: 10.1371/journal.pone.0156806. eCollection 2016.
4
Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC.晚期单侧视网膜母细胞瘤:眼动脉化疗手术对MSKCC眼球摘除率和患者生存率的影响
PLoS One. 2015 Dec 28;10(12):e0145436. doi: 10.1371/journal.pone.0145436. eCollection 2015.
5
Salvage/adjuvant brachytherapy after ophthalmic artery chemosurgery for intraocular retinoblastoma.眼动脉化疗后挽救性/辅助近距离放射治疗眼内视网膜母细胞瘤。
Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):517-23. doi: 10.1016/j.ijrobp.2013.06.2045. Epub 2013 Aug 14.
6
[Retinoblastoma].[视网膜母细胞瘤]
Ophthalmologe. 2006 Jan;103(1):59-76; quiz 77-8. doi: 10.1007/s00347-005-1296-1.
7
Chemotherapy for retinoblastoma: a current topic.视网膜母细胞瘤的化疗:当前话题
Drugs. 1999 Dec;58(6):983-96. doi: 10.2165/00003495-199958060-00003.
8
Three histopathological types of retinoblastoma and their relation to heredity and age of enucleation.视网膜母细胞瘤的三种组织病理学类型及其与遗传和眼球摘除年龄的关系。
J Med Genet. 1996 Nov;33(11):923-27. doi: 10.1136/jmg.33.11.923.
9
Unilateral retinoblastoma: new intraocular tumours after treatment.单侧视网膜母细胞瘤:治疗后的新发眼内肿瘤
Br J Ophthalmol. 1994 Sep;78(9):698-701. doi: 10.1136/bjo.78.9.698.
10
The diagnosis of retinoblastoma.视网膜母细胞瘤的诊断。
Bull N Y Acad Med. 1988 May;64(4):283-317.